Valuentum Exclusive Analysis for the Discerning Investor

Symbol Keyword

Member Login Email Password Join Now Forgotten Password Newsletters/Portfolios View Current and Archived Dividend Growth Newsletters View Current and Archived Best Ideas Newsletters Valuentum's Dividend Growth Newsletter Portfolio Valuentum's Best Ideas Newsletter Portfolio Order the Exclusive Publication! View Current and Archived Exclusive Editions Order the High Yield Dividend Newsletter! Dividend Cushion Efficacy Calculation Dividend-Adjusted Leverage White Paper Stock Screens How to Filter Data in Microsoft Excel Like a Pro Download Weekly Stock Screener (xls) -- login required The Quarterly DataScreener Products & Tools Financial Advisor (GOLD LEVEL) Publications DCF Valuation Model Template Order Value Trap Order Value Trap, second edition Value Trap Order PDF Copy Order Paperback Copy Presentation BookLife Review BlueInk Review Foreword Review Readers' Favorite Review Axiom Bronze Praise The Buying Index, VBI Value and Momentum Within Stocks, Too (2017) The Case for the Valuentum Style of Investing (2012) Investing's Odd Couple: Value and Momentum (2013) Stock-Selection Methodology, the Valuentum Buying Index (2011) Why Valuentum Buying Index Ratings Matter (2014)

Results 91 - 100 of 219 for cl. (2.17 seconds) Finisar Rides the Cloud to Success Data center spending helps lift Finisar’s results... Legal Costs Cloud Citigroup’s Earnings Potential Citi’s operations are improving, but legal expenses... “I’d rather lose half of my clients than lose half of my clients’ money.” Let’s talk a little more about perspective. Cliffs Natural's Blunder; The Dividend Cushion Not Fooled Valuentum's President Brian Nelson talks about how income... Oracle's Cloud Performance Leaves a Hazy Overall Outlook Oracle’s shares took a hit after... Transaction Alerts: Moving Closer to Market Neutral on Energy The absence of energy exposure in the Best Ideas... Follow Up on Loxo Oncology, Clovis Oncology, and Nevro We like to write about a wide range of ideas in the... Three Blow Ups after the Close February 4 It won’t be pretty for shares of LinkedIn, Deckers,... Looking Closely at Zimmer Biomet Image Source: Zimmer Biomet. Medical technology... The Dreaded Patent Cliff: 3 Pharmaceutical Companies at Risk Image Source: Global Panorama. Let's have a look at... prev | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | next